Marc M.
- Country
- Germany
- Department
- Klinik für Strahlentherapie und Radioonkologie
Research Overview
- INDIE: Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma
- Evaluation of Morphologic Complete Response in Early Stage Nodal Follicular Lymphoma with Rituximab or Obinutuzumab Plus Radiotherapy
- Evaluation of Irinotecan, Ifosfamide, Vincristine, and Dactinomycin in Frontline and Relapsed Rhabdomyosarcoma in Pediatric and Adult Populations
Data & Insights
Has run more than one trial at 43 of 234 partner sites.
Specializations
Gastrointestinal Oncology
This investigator specializes in the treatment of anal carcinoma and rectal cancer, with particular focus on organ preservation strategies and innovative therapeutic approaches.
- Advanced anal cancer management
- Radiochemotherapy protocols
- Organ preservation techniques
Their work encompasses comprehensive treatment strategies for intermediate and high-risk colorectal malignancies.
Lymphoma Treatment
The investigator demonstrates expertise in treating classical Hodgkin lymphoma and follicular lymphoma, particularly focusing on early-stage disease management.
- Immunotherapy applications
- PET-guided treatment strategies
- Combined modality approaches
Their research includes innovative antibody-based therapies integrated with conventional treatment modalities.
Therapeutic Innovation
The investigator develops personalized treatment approaches incorporating novel therapeutic agents with established protocols.
- Immune checkpoint inhibition
- Targeted radiotherapy techniques
- Multi-modal treatment strategies
Their work focuses on optimizing treatment outcomes through individualized therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.